These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9680247)

  • 1. The role of subtypes of the opioid receptor in the anxiolytic action of chlordiazepoxide.
    Agmo A; Belzung C
    Neuropharmacology; 1998; 37(2):223-32. PubMed ID: 9680247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical anxiolytic-like response to naloxone in benzodiazepine-resistant 129S2/SvHsd mice: role of opioid receptor subtypes.
    Rodgers RJ; Augar R; Berryman N; Hansom CJ; O'Mahony ML; Palmer RM; Stevens A; Tallett AJ
    Psychopharmacology (Berl); 2006 Aug; 187(3):345-55. PubMed ID: 16802164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of the opioid system in the anxiolytic-like effects induced by Delta(9)-tetrahydrocannabinol.
    Berrendero F; Maldonado R
    Psychopharmacology (Berl); 2002 Aug; 163(1):111-7. PubMed ID: 12185408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of the opioid system in the effects induced by nicotine on anxiety-like behaviour in mice.
    Balerio GN; Aso E; Maldonado R
    Psychopharmacology (Berl); 2005 Sep; 181(2):260-9. PubMed ID: 15778877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naloxone potentiates the effects of subeffective doses of anxiolytic agents in mice.
    Belzung C; Agmo A
    Eur J Pharmacol; 1997 Apr; 323(2-3):133-6. PubMed ID: 9128831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naltrexone potentiates the anxiolytic effects of chlordiazepoxide in rats exposed to novel environments.
    Frussa-Filho R; Barbosa-Júnior H; Silva RH; Da Cunha C; Mello CF
    Psychopharmacology (Berl); 1999 Nov; 147(2):168-73. PubMed ID: 10591884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naloxone potentiates the anxiolytic but not the amnestic action of chlordiazepoxide in C57BL/6 mice.
    Belzung C; Dubreuil D
    Behav Pharmacol; 1998 Dec; 9(8):691-8. PubMed ID: 9890259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mu-opioid receptor knockout mice are more sensitive to chlordiazepoxide-induced anxiolytic behavior.
    Wang KC; Lee YJ; Fan LW; Yang PP; Tao PL; Ho IK; Tien LT
    Brain Res Bull; 2013 Jan; 90():137-41. PubMed ID: 23142328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of the opioid system in the anxiolytic effect of diazepam in mice.
    Tsuda M; Suzuki T; Misawa M; Nagase H
    Eur J Pharmacol; 1996 Jun; 307(1):7-14. PubMed ID: 8831097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BOC-CCK-4, CCK(B)receptor agonist, antagonizes anxiolytic-like action of morphine in elevated plus-maze.
    Kõks S; Soosaar A; Võikar V; Bourin M; Vasar E
    Neuropeptides; 1999 Feb; 33(1):63-9. PubMed ID: 10657473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of delta opioid receptors in the anxiolytic actions of benzodiazepines.
    Primeaux SD; Wilson SP; McDonald AJ; Mascagni F; Wilson MA
    Pharmacol Biochem Behav; 2006 Nov; 85(3):545-54. PubMed ID: 17109943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enkephalin analog, cyclo[N(ε),N(β)-carbonyl-D-Lys(2),Dap(5)] enkephalinamide (cUENK6), inhibits the ethanol withdrawal-induced anxiety-like behavior in rats.
    Gibula-Bruzda E; Marszalek-Grabska M; Witkowska E; Izdebski J; Kotlinska JH
    Alcohol; 2015 May; 49(3):229-36. PubMed ID: 25716198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions between LY354740, a group II metabotropic agonist and the GABA(A)-benzodiazepine receptor complex in the rat elevated plus-maze.
    Ferris P; Seward E; Dawson GR
    J Psychopharmacol; 2001 Jun; 15(2):76-82. PubMed ID: 11448091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anxiolytic effects of ethanol are partially related to a reduced expression of adenylyl cyclase 5 but not to μ-opioid receptor activation in rat nucleus accumbens.
    Morales-Mulia M; Estrada-Camarena E; Amaya MI; Mejía-Mauríes S; Sollozo-Dupont I; Mengod G; de Gortari P
    Behav Brain Res; 2012 Dec; 235(2):189-94. PubMed ID: 22963992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of opioid receptor subtypes in antinociceptive actions of supraspinally-administered mitragynine in mice.
    Thongpradichote S; Matsumoto K; Tohda M; Takayama H; Aimi N; Sakai S; Watanabe H
    Life Sci; 1998; 62(16):1371-8. PubMed ID: 9585164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
    Baker AK; Meert TF
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DOR(2)-selective but not DOR(1)-selective antagonist abolishes anxiolytic-like effects of the δ opioid receptor agonist KNT-127.
    Sugiyama A; Nagase H; Oka J; Yamada M; Saitoh A
    Neuropharmacology; 2014 Apr; 79():314-20. PubMed ID: 24333676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The anxiolytic- and antidepressant-like effects of ATPM-ET, a novel κ agonist and μ partial agonist, in mice.
    Wang Q; Long Y; Hang A; Zan GY; Shu XH; Wang YJ; Liu JG
    Psychopharmacology (Berl); 2016 Jun; 233(12):2411-8. PubMed ID: 27113225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cocaine-like discriminative stimulus effects of heroin in squirrel monkeys: role of active metabolites and opioid receptor mechanisms.
    Rowlett JK; Spealman RD; Platt DM
    Psychopharmacology (Berl); 2000 Jun; 150(2):191-9. PubMed ID: 10907672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naltrexone potentiates both amnestic and anxiolytic effects of chlordiazepoxide in mice.
    Silva RH; Frussa-Filho R
    Life Sci; 2002 Dec; 72(6):721-30. PubMed ID: 12467912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.